Physicians still giving in to patient demands for branded drugs

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.670, 2013-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Costs for branded drugs up, generics down in US

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 625, 2011-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Would you pay more for branded drugs?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 624, 2011-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

US generics a better bet than off-shore branded drugs

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 553, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Medicaid spent an extra $US329 million in 2009 by buying 20 branded drugs instead of their generic equivalents

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 626, 2011-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Financial incentives for physicians lead to improved patient care

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 527, 2007-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite